产品封面图
研选

重组非典型肺炎病毒 (SARS) Spike/RBD 蛋白 (RBD, His标签)

收藏
  • ¥5820
  • Sino Biological已认证
  • 北京
  • 40150-V08B2
  • 2025年12月04日
    24h回复
    售后服务
    技术支持
    货源齐全
    文献支持
    avatar
  • 企业认证

    点击 QQ 联系

  • 研选banner
    • 详细信息
    • 用户评价
    • 文献和实验
    • 技术资料
    • 保存条件

      在-20℃ to -80℃

    • 保质期

      12个月

    • 英文名

      Recombinant SARS-CoV Spike/RBD Protein (RBD, His Tag)

    • 库存

      99

    • 供应商

      北京义翘神州科技股份有限公司

    • 规格

      100 µg

    SARS Coronavirus spike蛋白|Coronavirus spike protein|Coronavirus spike(SARS, C-His)(产品说明)
    蛋白名称:Coronavirus spike蛋白, Coronavirus spike protein
    蛋白构建:A DNA sequence encoding the receptor binding domain (RBD) of SARS-CoV (isolate:WH20) spike (AAX16192.1) (Arg306-Phe527) was expressed with a C-terminal polyhistidine tag.
    表达宿主:Baculovirus-Insect Cells
    蛋白纯度:> 95 % as determined by SDS-PAGE
    蛋白内毒素:< 1.0 EU per μg of the protein as determined by the LAL method
    预测N端:Arg 306
    蛋白分子量:The recombinant receptor binding domain (RBD) of SARS-CoV (isolate:WH20) spike comprises 233 amino acids and has a predicted molecular mass of 26.5 kDa. The apparent molecular mass of the protein is approximately 35.1 kDa in SDS-PAGE under reducing conditions.
    蛋白NP号:AAX16192.1
    蛋白氨基酸序列:Arg306-Phe527
    蛋白标签:C-His
    蛋白保存条件:Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标用户评价
      图标暂无用户评价
      图标文献和实验
      该产品被引用文献
      1, Chi X, et al. Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain.Nature communications, PubMed ID: 32913273
      2, Liu T, et al. Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substrates.Nature biomedical engineering, PubMed ID: 33122853
      3, Guo K, et al. Rapid single-molecule detection of COVID-19 and MERS antigens via nanobody-functionalized organic electrochemical transistors.Nature biomedical engineering, PubMed ID: 34031558
      4, Agarwal DK, et al. Highly sensitive and ultra-rapid antigen-based detection of SARS-CoV-2 using nanomechanical sensor platform.Biosensors & bioelectronics, PubMed ID: 34583103
      5, Li Y, et al. Structural and functional analysis of an inter-Spike bivalent neutralizing antibody against SARS-CoV-2 variants.iScience, PubMed ID: 35607524
      6, Hwu AT, et al. Centrifugal disc liquid reciprocation flow considerations for antibody binding to COVID antigen array during microfluidic integration.Lab on a chip, PubMed ID: 35737382
      7, Koklu A, et al. Convection Driven Ultrarapid Protein Detection via Nanobody-Functionalized Organic Electrochemical Transistors.Advanced materials (Deerfield Beach, Fla.), PubMed ID: 35772173
      8, Shim JE, et al. Single-Nanoparticle-Based Digital SERS Sensing Platform for the Accurate Quantitative Detection of SARS-CoV-2.ACS applied materials & interfaces, PubMed ID: 35951983
      9, Kassardjian A, et al. Modular adjuvant-free pan-HLA-DR-immunotargeting subunit vaccine against SARS-CoV-2 elicits broad sarbecovirus-neutralizing antibody responses.Cell reports, PubMed ID: 37053069
      10, Yu W, et al. Biosensor-based active ingredient recognition system for screening potential small molecular Severe acute respiratory syndrome coronavirus 2 entry blockers targeting the spike protein from Rugosa rose.Biomedical chromatography : BMC, PubMed ID: 39126351
      相关实验
      • 新冠病毒及变异株疫苗新突破:环状 RNA 疫苗

        日前,北京大学生命科学学院魏文胜课题组在 Cell 杂志上在线发表题为“Circular RNA Vaccines against SARS-CoV-2 and Emerging Variants”的研究论文。 魏文胜团队首先建立了体外高效制备高纯度环状 RNA 的技术平台,针对新型冠状病毒及其变异株,设计了编码新冠病毒刺突蛋白Spike)受体结构域(RBD)的环状 RNA 疫苗。 该项研究中制备的针对新冠病毒德尔塔变异株的环状 RNA 疫苗(circRNARBD

      • 全球首次!分离的新冠病毒中和抗体,还可同时抗 SARS 病毒

        抗原表位,为预防和治疗新型冠状病毒肺炎 COVID- 19 提供了可能。图片来源:bioRxiv通常,冠状病毒中和抗体主要靶向介导进入宿主细胞的病毒表面三聚体刺突糖蛋白Spike Glycoproteins,S 蛋白)。S 蛋白具有介导细胞附着的两个功能亚基:负责受体识别的 S1 亚基(存在四个核心结构域 S1 A/B/C/D)以及促使病毒与细胞膜融合的 S2 亚基。强大的中和抗体通常会靶向 S1 中的受体相互作用位点,从而使受体相互作用失效。之前的研究表明,SARS-CoV- 2 和 SARS-CoV

      • 中科院高福院士课题组 2020 年发表了哪些重要的研究成果?

        动物)的 ACE2 可以与 SARS-CoV-2 受体结合域(RBD)并促进 SARS-CoV-2 假病毒的转导。与 SARS-CoV-2 相比,SARS-CoV 似乎在选择受体方面有稍宽的范围。研究进一步以 3Å 分辨率解析了猫 ACE2(cACE2)与 SARS-CoV-2 RBD 的复合体的低温电子显微镜(cryo-EM)结构,揭示了与 hACE2 类似的结合模式与 SARS-CoV- 2 RBD。这些结果为寻找 SARS-CoV-2 的中间宿主提供了亮点,并强调了监控易感宿主以防止进一步爆发的必要

      图标技术资料

      暂无技术资料 索取技术资料

      研选
      重组非典型肺炎病毒 (SARS) Spike/RBD 蛋白 (RBD, His标签)
      ¥5820